Palbociclib + an aromatase inhibitor

DRUG2 trials

Sponsors

Pfizer

Conditions

Metastatic Breast Cancer

Unknown Phase

Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy

CompletedNCT04176354

PfizerMetastatic Breast Cancer

Start: 2019-01-25End: 2019-09-27Updated: 2024-08-23

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

CompletedNCT05361655

PfizerMetastatic Breast Cancer

Start: 2021-09-01End: 2021-09-01Updated: 2024-06-07

Related Papers

Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2- metastatic breast cancer: A Flatiron Health database analysis.

2025-03-17

Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectiveness

The Oncologist2024-10-172 citations

Prolonging the lives of African–Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice: a plain language summary of a real-world database study

Future Oncology2024-03-221 citations

Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older

Frontiers in Oncology2023-09-2818 citations

Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer

The Oncologist2023-07-249 citations

Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summary

Future Oncology2023-03-012 citations

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer.

2022-10-1190 citations

Real-World Effectiveness of Palbociclib Plus Letrozole vs Letrozole Alone for Metastatic Breast Cancer With Lung or Liver Metastases: Flatiron Database Analysis

Frontiers in Oncology2022-07-0411 citations

Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.

2022-05-0520 citations

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice.

2021-08-0223 citations

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice.

2021-03-2493 citations